chen qing
Kunming Medical University
Kunming, China
Review Editor
Pharmacology of Anti-Cancer Drugs
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Editorial Board
Type at least 3 characters
1,064 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
mingbo qu
Dalian University of Technology
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
yang qu
Jiangsu University
Zhenjiang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
vincenzo quagliariello
Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale
Naples, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
casey l quinlan
Pfizer
New York, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
michel record
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Pharmacology of Anti-Cancer Drugs
mauricio rodriguez-dorantes
National Institute of Genomic Medicine (INMEGEN)
Mexico City, Mexico
Review Editor
Pharmacology of Anti-Cancer Drugs
james m rae
Michigan Medicine, University of Michigan
Ann Arbor, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
md ataur rahman
University of Michigan
Ann Arbor, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
sunil s. raikar
Emory University
Atlanta, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
satish ramalingam
SRM Institute of Science and Technology
Chennai, India
Review Editor
Pharmacology of Anti-Cancer Drugs
maylis raphael
CVO-Europe
Brussels, Belgium
Review Editor
Pharmacology of Anti-Cancer Drugs
mohd ahmar rauf
University of Michigan
Ann Arbor, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
heather karen raymon
Celgene (United States)
Summit, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
ali razaghi
Karolinska Institutet (KI)
Solna, Sweden
Review Editor
Pharmacology of Anti-Cancer Drugs
jie ren
Changzhou University
Changzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs